cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment (Q36029498)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

author name string

Wilson AP

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ford CH

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Newman CE

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Howell A

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 December 1987

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

56

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

763-773

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Reactivity of a monoclonal antibody with human ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

A comparison of three assays used for the in vitro chemosensitivity testing of human tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

European studies with cisplatin and cisplatin analogs in advanced ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

Tissue culture studies of malignant effusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

Assay of anti-cancer drugs in tissue culture; conditions affecting their ability to incorporate 3H-leucine after drug treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

Direct cloning of human ovarian carcinoma cells in agar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

2 October 2017

High-dose carboplatin in refractory ovarian cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

11 July 2018

Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2002397

11 July 2018

Tissue cultures of ovarian carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term tissue cultures of human pleural effusions: a cytological follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake of melphalan by human ovarian carcinoma cells and its relationship to the amino acid content of ascitic fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective clinical trial of a human tumor cloning system

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 5-FU administered Ip to patients with refractory ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter: Predicting response of human cancer to chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3435704

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1987.285

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36029498&oldid=2198090131"